Nick Perry

Background

• Co-founded Candid Health in 2019 with Doug Proctor (COO); both are Palantir alumni, Perry spent roughly five years there on healthcare.
• Core thesis: medical billing is a data engineering problem, not a staffing problem. Candid submits claims correctly the first time instead of reworking denials.
• Y Combinator W20. HQ in San Francisco, with offices in New York and Denver.

Current focus

• Scaling beyond digital health and telehealth customers (Talkiatry, Nourish, Allara) into large multi-site physician groups.
• Pushing toward autonomous RCM: the Series C announcement cited touchless claim rates and payor net collection rates above 95%.
• Deploying the $120M Series D (July 2026, Sixth Street Growth) into AI capability and go-to-market. Growth to date has been largely word-of-mouth with minimal marketing spend.

What he cares about

• Durable infrastructure over quick wins. He frames Candid as payments infrastructure in the mold of Stripe or Shopify, and on exit plans has said "Stripe is a very large private company, and they seem great." Read that as limited near-term IPO or sale appetite.
• Proof through metrics: 190% YoY run-rate revenue growth and roughly 180% net dollar retention in 2025.

Potential sensitivities

• Exit timing and valuation specifics, given he has publicly downplayed IPO ambition.
• Competitive framing against both legacy RCM incumbents and the wave of new AI RCM entrants.
• Named customers, payor relationships, and contract economics are likely confidential.

Questions to ask

1. Where does automation still break down: which claim types or payors require human touch today, and what closes that gap?
2. How does the multi-site physician group motion differ from digital health on sales cycle, implementation load, and net retention?
3. With Sixth Street's growth capital in, which adjacencies (eligibility, patient collections, payor contracting) are on the roadmap, and would you consider M&A to get there?